DepoMed (DEPO) PT Bumped to $19 at Piper Jaffray, Remains Sidelined

August 4, 2016 7:29 AM

Piper Jaffray analyst David Amsellem bumped his price target on DepoMed Inc (NASDAQ: DEPO) to $19.00 (from $18.00) but maintained ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found